Homeostatic resilience, skin renewal: Taiyi Health at the 2026 PCHi Leaders Summit

On 12–13 August 2026, the PCHi Personal Care and Cosmetics Industry Leaders Summit and Innovative Technology Exhibition was held in Guangzhou.

Guangdong Qingyunshan TCM Innovation Research and Development Co., Ltd., a Taiyi Health subsidiary, presented two new cosmetic ingredients, MitoYouth® urolithin A and SenoFis™ fisetin. At the summit's forum on skin mechanisms and medical–research co-creation, Taiyi Health Scientific Director Kelly Yang was invited to speak on a cellular-homeostasis solution for stressed skin, bringing the industry a new way of thinking about cellular anti-ageing and repair based on a new paradigm of ageing.

A cellular-homeostasis solution for stressed skin: urolithin A and fisetin in anti-ageing and repair

Consumer demand for early anti-ageing and barrier repair keeps rising, and stressed skin has become a central topic. At its core, stressed skin is not a skin-type problem but a loss of homeostatic resilience. Skin ageing is the most fundamental driver of stressed skin; its essence is an imbalance in the cellular homeostasis network, and when internal and external stress exceeds the skin's capacity to recover over a sustained period, the skin enters an aged, stressed state.

Using the cellular homeostasis network as its theoretical framework, Taiyi Health dissected the mechanisms of skin ageing and a new concept of healthy ageing across four levels: information, foundation, execution and system. The company highlighted MitoYouth® urolithin A and SenoFis™ fisetin as a twin-pillar anti-ageing and repair ingredient combination, backed by a complete evidence chain from cellular mechanism to human efficacy, offering a full-chain solution for intervening in stressed skin.

Speaking to the industry through science, empowering products through innovation

As the 2026 PCHi Leaders Summit drew to a close, Taiyi Health's twin-pillar strategy of MitoYouth® urolithin A and SenoFis™ fisetin, supported by full-chain capability in scientific evidence and efficacy validation, showed partners across the value chain an innovative skin-longevity solution that moves from describing ageing to designing against it.